Mr Pablo Nogueira > Bofill Mir Abogados > Santiago, Chile > Lawyer Profile

Bofill Mir Abogados‘ public law department consists of experts in constitutional and administrative proceedings and evidences a caseload that extends to judicial reviews, as well as litigation before the local courts, Courts of Appeals, Supreme Court and Constitutional Court. The group is led by Cristián Franetovic, whose practice includes administrative law and litigation, regulatory matters, and environmental law. Senior associate Pablo Nogueira, whose career includes working at the Superintendence of Pensions and General Secretariat of the Presidency, provides key support, while name partner Octavio Bofill brings additional senior involvement in the sector. Former practice leader Jorge Barrera and senior associate Daniela Severin both recently departed the firm.

The June 2023 arrival of Andrea Abascal and her team -and indeed, much of their client list- has established Bofill Mir Abogados as a significant player in the life sciences’ sector. A ‘very accurate professional with great communication skills‘ Abascal (who also heads up the firm’s public law and regulated markets practices) advises on the regulatory aspects of food, medical devices, pharmaceutical laboratories, cosmetics, biotechnology, and agricultural and livestock services. More broadly, the practice handles product registration and marketing authorisations, food product advertising and labelling, personal data protection and clinical studies, along with consumer rights’ protection, life sciences-related M&A, the design of pharmaceutical campaigns and compliance issues (among other matters). A strong second tier of advisors includes public law director Cristián Franetovic; and senior associates Pablo Nogueira (regulatory and administrative law; litigation), Jorge Tisné N (corporate and commercial law, data privacy and regulated markets) and Anamaría Verdugo (regulated markets and life sciences). On the IP-side of the practice the team can also call on Manuel Bernet P (also a June 2023 arrival from Jara Del Favero Abogados) whose experience includes advising pharma and technology companies on matters ranging from joint ventures and licensing to unfair competition.